224 related articles for article (PubMed ID: 37133343)
21. Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.
Alapi K; Erdos M; Kovács G; Maródi L
Eur J Haematol; 2007 Jan; 78(1):86-8. PubMed ID: 17087743
[TBL] [Abstract][Full Text] [Related]
22. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
[TBL] [Abstract][Full Text] [Related]
23. AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.
McDermott DH; Lopez J; Deng F; Liu Q; Ojode T; Chen H; Ulrick J; Kwatemaa N; Kelly C; Anaya-O'Brien S; Garofalo M; Marquesen M; Hilligoss D; DeCastro R; Malech HL; Murphy PM
J Cell Mol Med; 2011 Oct; 15(10):2071-81. PubMed ID: 21070597
[TBL] [Abstract][Full Text] [Related]
24. Dysregulated stem cell niches and altered lymphocyte recirculation cause B and T cell lymphopenia in WHIM syndrome.
Zehentmeier S; Lim VY; Ma Y; Fossati J; Ito T; Jiang Y; Tumanov AV; Lee HJ; Dillinger L; Kim J; Csomos K; Walter JE; Choi J; Pereira JP
Sci Immunol; 2022 Sep; 7(75):eabo3170. PubMed ID: 36149943
[TBL] [Abstract][Full Text] [Related]
25. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
26. Plerixafor for the Treatment of WHIM Syndrome.
McDermott DH; Pastrana DV; Calvo KR; Pittaluga S; Velez D; Cho E; Liu Q; Trout HH; Neves JF; Gardner PJ; Bianchi DA; Blair EA; Landon EM; Silva SL; Buck CB; Murphy PM
N Engl J Med; 2019 Jan; 380(2):163-170. PubMed ID: 30625055
[TBL] [Abstract][Full Text] [Related]
27. Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.
Siedlar M; Rudzki Z; Strach M; Trzyna E; Pituch-Noworolska A; Błaut-Szlósarczyk A; Bukowska-Strakova K; Lenart M; Grodzicki T; Zembala M
Arch Immunol Ther Exp (Warsz); 2008; 56(6):419-25. PubMed ID: 19043667
[TBL] [Abstract][Full Text] [Related]
28. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
[TBL] [Abstract][Full Text] [Related]
29. Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.
Mc Guire PJ; Cunningham-Rundles C; Ochs H; Diaz GA
Clin Immunol; 2010 Jun; 135(3):412-21. PubMed ID: 20226738
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of stem cell engraftment on a WHIM.
Broxmeyer HE
J Clin Invest; 2018 Aug; 128(8):3240-3242. PubMed ID: 29939159
[TBL] [Abstract][Full Text] [Related]
31. [WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear].
Bock I; Dugué F; Loppinet E; Bellanné-Chantelot C; Bénet B
Ann Biol Clin (Paris); 2014; 72(1):111-9. PubMed ID: 24492099
[TBL] [Abstract][Full Text] [Related]
32. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.
McDermott DH; Liu Q; Velez D; Lopez L; Anaya-O'Brien S; Ulrick J; Kwatemaa N; Starling J; Fleisher TA; Priel DA; Merideth MA; Giuntoli RL; Evbuomwan MO; Littel P; Marquesen MM; Hilligoss D; DeCastro R; Grimes GJ; Hwang ST; Pittaluga S; Calvo KR; Stratton P; Cowen EW; Kuhns DB; Malech HL; Murphy PM
Blood; 2014 Apr; 123(15):2308-16. PubMed ID: 24523241
[TBL] [Abstract][Full Text] [Related]
33. Dysplasia of Granulocytes in a Patient with HPV Disease, Recurrent Infections, and B Lymphopenia: A Novel Variant of WHIM Syndrome?
Moscato GMF; Giacobbi E; Anemona L; Di Cesare S; Di Matteo G; Andreoni M; Mauriello A; Moschese V
Front Pediatr; 2017; 5():95. PubMed ID: 28512628
[TBL] [Abstract][Full Text] [Related]
34. Periodontal disease in patients with WHIM syndrome.
Brenchley L; McDermott DH; Gardner PJ; Silva LM; Gao JL; Cho E; Velez D; Moutsopoulos NM; Murphy PM; Fraser D
J Clin Periodontol; 2024 Apr; 51(4):464-473. PubMed ID: 38185798
[TBL] [Abstract][Full Text] [Related]
35. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.
Balabanian K; Levoye A; Klemm L; Lagane B; Hermine O; Harriague J; Baleux F; Arenzana-Seisdedos F; Bachelerie F
J Clin Invest; 2008 Mar; 118(3):1074-84. PubMed ID: 18274673
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9-mediated Cxcr4 disease allele inactivation for gene therapy in a mouse model of WHIM syndrome.
Gao JL; Owusu-Ansah A; Yang A; Yim E; McDermott DH; Jacobs P; Majumdar S; Choi U; Sweeney CL; Malech HL; Murphy PM
Blood; 2023 Jul; 142(1):23-32. PubMed ID: 36928087
[TBL] [Abstract][Full Text] [Related]
37. CXCR4 mutations in WHIM syndrome: a misguided immune system?
Diaz GA
Immunol Rev; 2005 Feb; 203():235-43. PubMed ID: 15661033
[TBL] [Abstract][Full Text] [Related]
38. Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice.
Balabanian K; Brotin E; Biajoux V; Bouchet-Delbos L; Lainey E; Fenneteau O; Bonnet D; Fiette L; Emilie D; Bachelerie F
Blood; 2012 Jun; 119(24):5722-30. PubMed ID: 22438253
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.
Dotta L; Notarangelo LD; Moratto D; Kumar R; Porta F; Soresina A; Lougaris V; Plebani A; Smith CIE; Norlin AC; Gòmez Raccio AC; Bubanska E; Bertolini P; Amendola G; Visentini M; Fiorilli M; Venuti A; Badolato R
J Allergy Clin Immunol Pract; 2019; 7(5):1568-1577. PubMed ID: 30716504
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Sustained Neutrophilia in Patient WHIM-09, Cured of WHIM Syndrome by Chromothripsis.
Liu Q; Li Z; Y Yang A; Gao JL; S Velez D; J Cho E; McDermott DH; Murphy PM
J Clin Immunol; 2018 Jan; 38(1):77-87. PubMed ID: 29177911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
